Literature DB >> 19774630

An improved microalbumin method (microALB_2) with extended analytical measurement range evaluated on the ADVIA chemistry systems.

Pradip Datta1, Amitava Dasgupta.   

Abstract

Quantitative determination of albumin (ALB) in human urine is important to assess kidney functions in a variety of diseases. Recently, Siemens released an improved Microalbumin assay (microALB_2) to measure urinary ALB on the automated, random access ADVIA 1650/1800, ADVIA 2400, and ADVIA 1200 Chemistry Systems. We evaluated analytical performances of this new method. All ADVIA Chemistry Systems use the same microalbumin reagent packs, microALB_2 calibrators, and commercial controls. The within-run and total CVs of the improved method with two-level BioRad Liquichek Urine Chemistry controls (approximately 2 and 9 mg/dl ALB) and a urine pool (approximately 29 mg/dl ALB) on all ADVIA Chemistry systems were <4.1 and <6.1%, respectively (40 replicates per sample). The analytical range/linearity of the method (all ADVIA systems) was from 0.3 mg/dl to theALB concentration in the highest level of calibrator (approximately 38-42 mg/dl). The improved method (microALB_2) on the ADVIA 1650/1800 (y) correlated well with both the Beckman DXC 800 Microalbumin and the old microalbumin method on the ADVIA 1650/1800 analyzers. The improved method showed <10% interference with 16 chemicals from acetaminophen to uric acid that may be present in urine. The improved method has a minimum of 60 days' on-system stability on all systems with the calibration frequencies of (with/without a Reagent Container insert) 20/30 days (ADVIA1200), 50/60 days (ADVIA1650/1800), and 20/60 days (ADVIA2400). No prozone was observed with the method on any platform up to the highest ALB concentration tested in a sample (4,000 mg/dl).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774630      PMCID: PMC6649169          DOI: 10.1002/jcla.20341

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Microalbuminuria measurements by two in-house ELISA methods.

Authors:  L C Ng; L C Teng; M L Ng; B S Sazali; B A Khalid
Journal:  Malays J Pathol       Date:  2000-12       Impact factor: 0.656

Review 2.  Rationale for albumin infusions.

Authors:  Peter B Soeters
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-05       Impact factor: 4.294

3.  Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease.

Authors:  Kathleen T McKie; Coral D Hanevold; Caterina Hernandez; Jennifer L Waller; Luis Ortiz; Kathleen M McKie
Journal:  J Pediatr Hematol Oncol       Date:  2007-03       Impact factor: 1.289

4.  Quantitation of microalbuminuria using random urine samples.

Authors:  Farahnak K Assadi
Journal:  Pediatr Nephrol       Date:  2002-02       Impact factor: 3.714

5.  Urine microalbumin excretion in relation to exercise-induced electrocardiographic myocardial ischaemia.

Authors:  Julian S Waldron; Yetunde Baoku; Andrew J Hartland; Neil R Anderson; Richard Horton; Rousseau Gama
Journal:  Med Sci Monit       Date:  2002-11

6.  Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK Microalbumin and DCA 2000+ for the rule-out of albuminuria in chronic kidney disease.

Authors:  Mark Guy; Ronald Newall; Joanna Borzomato; Philip A Kalra; Christopher Price
Journal:  Clin Chim Acta       Date:  2008-09-14       Impact factor: 3.786

7.  Abnormal urinary protein excretion in HIV-infected patients.

Authors:  P L Kimmel; W O Umana; J P Bosch
Journal:  Clin Nephrol       Date:  1993-01       Impact factor: 0.975

8.  Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection.

Authors:  U Meinhardt; R A Ammann; C Flück; P Diem; P E Mullis
Journal:  J Diabetes Complications       Date:  2003 Sep-Oct       Impact factor: 2.852

9.  Investigation of microalbuminuria in nondiabetic, normotensive obese women.

Authors:  Tijen Erdem Yesim; Serdal Ugurlu; Erkan Caglar; Huriye Balci; Ayca Ucgul; Cihat Sarkis; Ozer Acbay; Sadi Gundogdu
Journal:  Intern Med       Date:  2007-12-17       Impact factor: 1.271

Review 10.  Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.

Authors:  Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-03       Impact factor: 3.738

  10 in total
  4 in total

1.  Hypertension is associated with increased post-exercise albuminuria, which may be attenuated by an active lifestyle.

Authors:  Ayelet Grupper; Michal Ehrenwald; Doron Schwartz; Shlomo Berliner; Moshe Shashar; Roni Baruch; Idit F Schwartz; Ori Rogowski; David Zeltser; Itzhak Shapira; Shani Shenhar-Tsarfaty
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-08       Impact factor: 3.738

2.  Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings.

Authors:  Rafael Y Brzezinski; Inbal Etz-Hadar; Ayelet Grupper; Michal Ehrenwald; Itzhak Shapira; David Zeltser; Shlomo Berliner; Ori Rogowski; Roy Eldor; Shani Shenhar-Tsarfaty
Journal:  Cardiovasc Diabetol       Date:  2017-06-23       Impact factor: 9.951

3.  High-performance immunosensor for urine albumin using hybrid architectures of ZnO nanowire/carbon nanotube.

Authors:  Mohamad Kazem Tabatabaei; Hassan Ghafori Fard; Javad Koohsorkhi; Javad Mohammadnejad Arough
Journal:  IET Nanobiotechnol       Date:  2020-04       Impact factor: 1.847

4.  Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism.

Authors:  Rafael Y Brzezinski; Limor Friedensohn; Itzhak Shapira; David Zeltser; Ori Rogowski; Shlomo Berliner; Ayelet Grupper; Shani Shenhar-Tsarfaty
Journal:  Cardiovasc Diabetol       Date:  2020-06-15       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.